We conclude that by evaluating the kidneys with sonography and calculating eGFR using MDRD formula the renal status will be more accurately interpreted.
0Estrogens protect against diet-induced obesity in women and female rodents. In support of these 2 1 anorectic effects, lack of estrogens in postmenopausal women is associated with weight gain, 2 2 increasing their risk for cardiovascular diseases and cancer. Estrogens act with leptin, a satiety 2 3 2 hormone encoded by the ob gene, to regulate energy homeostasis in females. Leptin-deficient 1 mice (ob/ob) exhibit morbid obesity and insulin resistance. In addition to estrogens and leptin, 2 the gut microbiome (gut microbes and their metabolites), is critical in regulating energy 3 metabolism. The present study investigates whether estrogens and leptin modulate gut 4 microbiota in ovariectomized ob/ob (obese) or heterozygote (lean) control mice fed a high-fat 5 diet (HFD) that received either 17β-Estradiol (E2) or vehicle implants. E2 attenuated weight gain 6 in both genotypes compared to vehicle counterparts. Moreover, both obesity (ob/ob mice) and 7 E2 reduced gut microbial diversity. ob/ob mice exhibited lower species richness than control 8 mice, while E2-treated mice had reduced evenness compared to vehicle mice. Regarding taxa, 9 E2 treatment was associated with higher abundances of the family S24-7. Leptin was associated targeting the gut microbiome for hormone-dependent metabolic disorders in women. 1 6 1 7 1 8 1 9 2 1and behavior [4][5][6]. Estrogens reduce food intake, attenuate body weight gain and adiposity, and 2 2 increase physical activity in both humans and rodents [1, 2]. Postmenopausal women have lower 2 3 3 levels of circulating estrogens and an increased tendency to gain fat weight, which increases their 1 risk for obesity, cardiovascular disease, stroke, and type 2 diabetes [7][8][9]. Similarly, in mice on a 2 high-fat diet (HFD), ovariectomy increases energy intake and the development of obesity, while 3 estradiol (E2) treatment prevents weight gain [2,[10][11][12][13], indicating that estrogens protect against 4 HFD-induced obesity. 6Leptin is a peptide hormone secreted primarily by adipocytes, which acts in the brain to stimulate 7 metabolism, promote satiety, and regulate fat storage [14][15][16]. A mutation in the ob gene that 8 encodes leptin results in mice lacking the hormone (ob/ob) [17]. While phenotypically normal at 9 birth, ob/ob mice quickly develop obesity and diabetes [18]. Additionally, ob/ob mice exhibit 1 0 increased food intake and decreased physical activity, energy metabolism, and body temperature 1 1 compared to lean controls, making ob/ob mice an excellent genetic model of obesity [19][20][21]. 2Administering leptin to adult ob/ob mice reverses these effects by decreasing food intake, 1 3 increasing energy output and decreasing circulating levels of glucose and insulin [22, 23]. 1 4 1 5Leptin and estrogen signaling pathways interact to influence reproduction and energy 1 6 metabolism. High levels of E2 are associated with increased leptin sensitivity in both male and 1 7 female rodents [24]. In mice, ovariectomy decreases leptin sensitivity, but can be restored by E2 1 ...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.